Dexamethasone Sodium Phosphate

   
Google
 
Web NewDrugInformation.com

Dexamethasone Sodium Phosphate


Drug - Dexamethasone Sodium Phosphate
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Dexamethasone Sodium Phosphate
Multiple ingredients are in alphabetical order.

Strength - EQ 4MG PHOSPHATE/ML
The potency of the active ingredient(s), Dexamethasone Sodium Phosphate. May repeat for multiple part products.

Applicant - STERIS
The firm name holding legal responsibility for Dexamethasone Sodium Phosphate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 083702
The FDA assigned number to Dexamethasone Sodium Phosphate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Dexamethasone Sodium Phosphate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Dexamethasone Sodium Phosphate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Dexamethasone Sodium Phosphate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Dexamethasone Sodium Phosphate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Steris Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Dexamethasone Sodium Phosphate.

Dexamethasone Sodium Phosphate